Buy Oxycodone? Pharmacies Having Hard Time Getting
Oxycodone - OxyContin - Oxycotton
OxyContin and Oxycodone
Even if you have a prescription for Oxy codone or Oxy
Contin you may have a hard time finding a pharmacy who can fill
it. The following article will explain what is happening to
the narcotics and pain killer industry. Will there be more
problems with pain killer withdrawal and side effects?
Pain drug in short supply
Federal drug rules, lawsuits hinder oxycodone production
By Tom Vogt
Columbian staff writer
Even a prescription for oxycodone isn’t always enough to
bring relief from pain these days. Some customers report
walking away empty-handed from the pharmacy.
“There is a shortage,” said Bill Fassett, a Washington State
University pharmacy professor.
It stems from a combination of factors. Oxycodone is a
narcotic pain reliever derived from morphine, so it’s a
controlled substance.
The Drug Enforcement Administration restricts the production
of generic oxycodone, which comes in different strengths and
formulations. The restriction includes related medications like
OxyContin, a brand-name drug sold in an extended-release
formulation.
Both medications are subject to abuse as street drugs, so
the DEA keeps a tight rein on their production to prevent
abuse.
“The government sets production quotas, based on estimated
annual needs,” said Fassett, vice-chair of WSU’s Department of
Pharmacotherapy. If demand exceeds a manufacturer’s annual
quota, some might run out in October, Fassett said.
Producers aren’t the only ones under sharp federal scrutiny,
said Mike Graeff, longtime Vancouver pharmacist.
“The DEA controls the production of pain medication on a
national basis, monitoring all levels of dispensing and
prescribing,” said Graeff, owner of Mike’s Eastside Drugs and
Homecare Equipment. “They look at a pharmacy, and if it exceeds
the amount, you’re red-flagged. You have to explain why it’s
peaking.”
Graeff, who just sold the pharmacy side of his store to
Walgreen Co., said he had to disappoint some walk-in customers
over the last six weeks or so.
“If they weren’t our patients, we haven’t been able take
care of them,” Graeff said.
Graeff knows how the drug can be diverted by criminals. “In
our last robbery, that was the drug they took,” Graeff said.
“They took it away from somebody who needed it.”
DEA restrictions aren’t the only crimp in the pipeline,
Fassett said. Some companies have stopped making oxycodone
after being sued for patent infringement by Purdue Pharma,
Fassett said.
A couple of years ago, “Five companies were making generic
extended-release oxycodone,” he said. And now, “Four companies
have discontinued production.”
The one company that is still making that version of
oxycodone said the product is on back-order. According to the
Web site of the American Society of Health-System Pharmacists,
which provides a list of drugs in short supply, the
manufacturer could not provide a reason for the shortage.
The Web site (www.ashp.org) also lists shortages of
immediate-release oxycodone from six different manufacturers:
five of them cite manufacturing issues or issues of supply and
demand.
Some regional health-care providers, where a patient can go
right from the physician to the pharmacist, are able to handle
things within their own systems.
“We can only fill a prescription for certain people,” said
Lonnye Finneman, assistant director of pharmacy at Southwest
Washington Medical Center. “We’re not a retail pharmacy. We’re
only allowed to fill prescriptions for our patients and our
outpatients.”
The shortage “hasn’t affected any of our patients’ access to
adequate pain control,” said Kaiser Permanente’s Dr. Sean
Jones.
While there has been a shortage of the generic oxycodone,
the brand-name product has been available, said Jones, chairman
of the regional formulary and therapeutics committee.
However, since OxyContin is an extended-release formulation,
it doesn’t always help patients looking for immediate pain
relief, pharmacists say. And, like other products, the
brand-name medication is significantly more expensive than the
generic.
WSU’s Fassett has some suggestions for people who don’t get
their care through full-service health systems.
“The best strategy for the long term is to consistently use
the same pharmacists and have a relationship with them,”
Fassett said.
See how flexible your physician will be about changing the
dosing, he said.
The patient who is unable to continue on a narcotic-based
pain-relief program faces a double challenge, Fassett added.
“They’re at risk of not only having pain, but withdrawal.”
http://columbian.com/article/20090201/NEWS02/702019952
Make sur to check wiht you pharmacist to make sure they have
am addeqaute sup;y if you need to take these painkillers.
Also speelld oxycotton and oxy contin.
|